Cyclo Therapeutics (CYTHW) Competitors $0.30 +0.01 (+3.10%) As of 01/22/2025 02:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends CYTHW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Cyclo Therapeutics stock or one of its competitors? The main competitors of Cyclo Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Cyclo Therapeutics vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity 180 Life Sciences (NASDAQ:ATNFW) and Cyclo Therapeutics (NASDAQ:CYTHW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation. Does the media favor ATNFW or CYTHW? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Cyclo Therapeutics'average media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Cyclo Therapeutics Neutral Is ATNFW or CYTHW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Cyclo Therapeutics N/A N/A N/A Which has higher valuation & earnings, ATNFW or CYTHW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ACyclo Therapeutics$870.73KN/AN/AN/AN/A Does the MarketBeat Community prefer ATNFW or CYTHW? 180 Life Sciences and Cyclo Therapeutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ACyclo TherapeuticsN/AN/A SummaryCyclo Therapeutics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get Cyclo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTHW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYTHW vs. The Competition Export to ExcelMetricCyclo TherapeuticsDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.19B$5.40B$9.25BDividend YieldN/A3.04%5.37%3.99%P/E RatioN/A131.5289.0517.52Price / SalesN/A2,885.841,226.5279.25Price / CashN/A10.2543.6036.96Price / BookN/A3.295.014.72Net IncomeN/A$152.21M$117.89M$224.61M7 Day Performance3.10%1.27%2.01%1.64%1 Month Performance139.39%3.67%4.00%5.24%1 Year Performance-9.37%103.18%26.71%21.42% Cyclo Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYTHWCyclo TherapeuticsN/A$0.30+3.1%N/A-9.4%$0.00$870,725.000.009Positive NewsGap UpATNFW180 Life SciencesN/A$0.01flatN/A+81.0%$0.00N/A0.007Positive NewsGap UpLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.03flatN/A-81.9%$0.00N/A0.002AIMDWAinosN/A$0.17flatN/A+50.0%$0.00$40,633.000.0040Gap DownALVOWAlvotechN/A$3.16-1.3%N/A-7.3%$0.00$391.87M0.004Gap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.06flatN/A+36.3%$0.00N/A0.004BFRIWBiofronteraN/A$0.08flatN/AN/A$0.00$35.36M0.0070BTMDWbioteN/A$0.51flatN/AN/A$0.00$193.06M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.15flatN/A-93.1%$0.00N/A0.008Positive NewsCELUWCelularityN/A$0.03flatN/A+39.3%$0.00$48.20M0.00220Positive News Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ACABW Competitors BFRIW Competitors BTMDW Competitors BCTXW Competitors CELUW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CYTHW) was last updated on 1/23/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDonald Trump is about to free crypto from its chains …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredThe #1 Stock for Trump’s Second Term?Imagine how much money you could make if you bought all of the top performing stocks during Trump's second ter...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
